Cargando…

Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma

Circulating microbial dysbiosis is associated with chronic liver disease including nonalcoholic steatohepatitis and alcoholic liver disease. In this study, we evaluated whether disease-specific alterations of circulating microbiome are present in patients with cirrhosis and hepatocellular carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Eun Ju, Leem, Sangseob, Kim, Sun Ah, Yang, Jinho, Lee, Yun Bin, Kim, Soon Sun, Cheong, Jae Youn, Cho, Sung Won, Kim, Ji Won, Kim, Sung-Min, Yoon, Jung-Hwan, Park, Taesung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525191/ https://www.ncbi.nlm.nih.gov/pubmed/31101866 http://dx.doi.org/10.1038/s41598-019-44012-w

Ejemplares similares

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor
por: Kim, Se Ik, et al.
Publicado: (2020)

EFMDR-Fast: An Application of Empirical Fuzzy Multifactor Dimensionality Reduction for Fast Execution
por: Leem, Sangseob, et al.
Publicado: (2018)

An empirical fuzzy multifactor dimensionality reduction method for detecting gene-gene interactions
por: Leem, Sangseob, et al.
Publicado: (2017)

Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment
por: Kim, Sun Ah, et al.
Publicado: (2020)

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
por: Kim, Si-Cho, et al.
Publicado: (2023)

MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020)

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011)

Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2020)

GxGrare: gene-gene interaction analysis method for rare variants from high-throughput sequencing data
por: Kwon, Minseok, et al.
Publicado: (2018)

Enhanced Permutation Tests via Multiple Pruning
por: Leem, Sangseob, et al.
Publicado: (2020)

Effect of Interaction between Early Menarche and Genetic Polymorphisms on Triglyceride
por: Lee, Ho-Sun, et al.
Publicado: (2019)

Association of Polymorphism in MicroRNA 604 with Susceptibility to Persistent Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma
por: Cheong, Jae Youn, et al.
Publicado: (2014)

Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics
por: Lee, Ji-Hyang, et al.
Publicado: (2020)

Fuzzy set-based generalized multifactor dimensionality reduction analysis of gene-gene interactions
por: Jung, Hye-Young, et al.
Publicado: (2018)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2017)

Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma
por: Woo, Hyun Goo, et al.
Publicado: (2014)

Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2023)

Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
por: Kim, Young Jip, et al.
Publicado: (2013)

Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma
por: Lee, Gil Ho, et al.
Publicado: (2021)

Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22
por: Cho, Okki, et al.
Publicado: (2012)

Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Association of Polymorphism in Pri-microRNAs-371-372-373 with the Occurrence of Hepatocellular Carcinoma in Hepatitis B Virus Infected Patients
por: Kwak, Min-Sun, et al.
Publicado: (2012)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
por: Kim, Da Jung, et al.
Publicado: (2019)

Effect of Next-Generation Exome Sequencing Depth for Discovery of Diagnostic Variants
por: Kim, Kyung, et al.
Publicado: (2015)

Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles
por: Kim, Da Jung, et al.
Publicado: (2020)

Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
por: Ahn, Young-Hwan, et al.
Publicado: (2021)

Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer
por: Jeong, Hyun-hwan, et al.
Publicado: (2015)

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
por: Han, Ji Eun, et al.
Publicado: (2021)

Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
por: Cho, Hyo Jung, et al.
Publicado: (2014)

Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment
por: Jun, Chung Hwan, et al.
Publicado: (2017)

Cellular Prion Protein Is Closely Associated with Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma
por: Kim, Mo-Jong, et al.
Publicado: (2022)

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
por: Hwang, Joo An, et al.
Publicado: (2015)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
por: Ahn, Young-Hwan, et al.
Publicado: (2022)

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
por: Eun, Jung Woo, et al.
Publicado: (2023)

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma
por: Son, Ju A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r00s97fi1p0fj1n8ii6qi8sgek